Icahn School of Medicine at Mount Sinai-Clinical and Translational Research Center

New York, New York 10029

0 studies enrolling now · 2 studies all time

What they study most

HIV Pre-exposure Prophylaxis, HIV-1 Infection

Studies at this site

• Study of Lenacapavir as a Once-Yearly Injection for HIV Pre-exposure Prophylaxis (PrEP) — Running, not enrolling
• Study to Evaluate the Safety and Efficacy of Teropavimab and Zinlirvimab in Combination With Lenacapavir in Virologically Suppressed Adults With HIV-1 Infection — Completed